Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multicenter, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of TAK-085 in Subjects With Hypertriglyceridemia.

NCT01350973 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT01350973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01350973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multicenter, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of TAK-085 in Subjects With Hypertriglyceridemia.
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2009
Completion date
December 31, 2010
Enrollment
611 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertriglyceridemia